Kevin Koch - 01 May 2022 Form 4 Insider Report for Edgewise Therapeutics, Inc. (EWTX)

Role
President and CEO, Director
Signature
/s/John R. Moore Attorney-in-Fact for Kevin Koch
Issuer symbol
EWTX
Transactions as of
01 May 2022
Net transactions value
$0
Form type
4
Filing time
03 May 2022, 16:14:14 UTC
Previous filing
19 Aug 2021
Next filing
10 Aug 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction EWTX Restricted Stock Units Award $0 +31,250 $0.000000 31,250 01 May 2022 Common Stock 31,250 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 RSUs granted to the reporting person for no additional cash consideration, each of which represent a contingent right to receive one share of Edgewise Therapeutics, Inc. common stock upon the vesting of these RSUs in three equal annual installments beginning on May 1, 2023.